Esticast Logo
Get In Touch!

Cardiopulmonary Autotransfusion Systems Market By Device (On-pump transfusion device, Off- pump transfusion device), By Application (Organ Transplant Surgery, Heart Surgery), By End-users (Hospitals,Cardiac Research Centers,Ambulatory Surgical Center), Industry Trends, Estimation & Forecast, 2017-2025

  • Published On: Jun, 2018
  • Category: Healthcare
  • Pages: 178
Cardiopulmonary Autotransfusion Systems Market is expected to grow with a CAGR of 1.8% during the forecast period of 2018 to 2025.

Market Overview:

The rise in number of complications during cardiovascular surgeries due to the transfer of blood from another sources led to the advent of auto-transfusion systems. Cardiopulmonary auto-transfusion systems enable the transfusion of autologous blood during the cardiovascular surgeries, thus limiting the number of complications arising due to the usage of allogenic blood. The surge in number of cardiovascular surgeries and the growing geriatric populace across the globe are the main determinants fuelling the growth of global cardiopulmonary autotransfusion systems market. Since the launch of STS Adult Cardiac Surgery Database (ACSD) in 1989, more than 6.3 million cardiac surgeries have been recorded in the database and is expected to surge during the upcoming years. The database also maintains a record of more than 3,100 participating physicians that includes surgeons and anesthesiologists. Moreover, increasing adoption of nouveau technology in medical procedures and rising investments in healthcare are also anticipated to boost the demand of cardiopulmonary autotransfusion systems. However, the high cost of such systems is expected to create hurdles in the global adoption of cardiopulmonary autotransfusion systems and thus hinder the market growth. The cardiopulmonary autotransfusion systems market is highly competitive in nature, due to the presence of several market players. Thus, the market players are focusing on product innovation as their main growth strategy to survive in such a competitive market. The report provides detailed qualitative and quantitative analysis of the cardiopulmonary autotransfusion systems market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely device, end-user, and application in each of the major regions.

Cardiopulmonary Autotransfusion Systems Market Segmentation

By Device • On-pump transfusion device • Off- pump transfusion device By Application • Organ Transplant Surgery • Heart Surgery • Others By End-user • Hospitals • Cardiac Research Centers • Ambulatory Surgical Center By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America  • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET OVERVIEW 2.1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET INTRODUCTION 25 2.2. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Cardiopulmonary Autotransfusion Systems Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Cardiopulmonary Autotransfusion Systems Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Cardiopulmonary Autotransfusion Systems Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Cardiopulmonary Autotransfusion Systems Consumption (VOLUME) and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET BY DEVICE, 2017-2025 29 3.1. ON-PUMP TRANSFUSION DEVICE 3.2. OFF- PUMP TRANSFUSION DEVICE 3.3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET REVENUE BY DEVICE, 2017-2025 3.3.1. Global Cardiopulmonary Autotransfusion Systems Market Revenue (Million USD) and Share (%) By Device, 2017-2025 3.3.2. On-pump transfusion device Market Revenue and Growth Rate, 2017-2025 3.3.3. Off- pump transfusion device Market Revenue and Growth Rate, 2017-2025 3.4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET PRODUCTION BY DEVICE, 2017-2025 3.4.1. Global Cardiopulmonary Autotransfusion Systems Market Production (Volume) and Share (%) By Device, 2017-2025 3.4.2. On-pump transfusion device Market Production and Growth Rate, 2017-2025 3.4.3. Off- pump transfusion device Market Production and Growth Rate, 2017-2025 CHAPTER 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET BY APPLICATION, 2017-2025 4.1. ORGAN TRANSPLANT SURGERY 4.2. HEART SURGERY 4.3. OTHERS 4.4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET REVENUE BY APPLICATION, 2017-2025 4.4.1. Global Cardiopulmonary Autotransfusion Systems Market Revenue (Million USD) and Share (%) By Application, 2017-2025 4.4.2. Organ Transplant Surgery Market Revenue and Growth Rate, 2017-2025 4.4.3. Heart Surgery Market Revenue and Growth Rate, 2017-2025 4.4.4. Others Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET CONSUMPTION BY APPLICATION, 2017-2025 4.5.1. Global Cardiopulmonary Autotransfusion Systems Market Consumption (Volume) and share (%) By Application, 2017-2025 4.5.2. Organ Transplant Surgery Market Consumption and Growth Rate, 2017-2025 4.5.3. Heart Surgery Market Consumption and Growth Rate, 2017-2025 4.5.4. Others Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for end-user segment. CHAPTER 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Cardiopulmonary Autotransfusion Systems Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Cardiopulmonary Autotransfusion Systems Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Cardiopulmonary Autotransfusion Systems Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Cardiopulmonary Autotransfusion Systems Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Cardiopulmonary Autotransfusion Systems Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Cardiopulmonary Autotransfusion Systems Market Share (%) of Top 3 Manufacturers 8.3.2. Cardiopulmonary Autotransfusion Systems Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MANUFACTURERS ANALYSIS 9.1. MEDTRONIC PLC. 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Cardiopulmonary Autotransfusion Systems Product Details 9.1.4. Medtronic Plc. Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.2. ADVANCIS SURGICAL 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Cardiopulmonary Autotransfusion Systems Product Details 9.2.4. Advancis Surgical Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.3. HAEMONETICS CORPORATION 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Cardiopulmonary Autotransfusion Systems Product Details 9.3.4. Haemonetics Corporation Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.4. LIVANOVA PLC 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Cardiopulmonary Autotransfusion Systems Product Details 9.4.4. LivaNova PLC Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.5. STRYKER CORPORATION 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Cardiopulmonary Autotransfusion Systems Product Details 9.5.4. Stryker Corporation Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.6. TERUMO INTERVENTIONAL SYSTEMS 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Cardiopulmonary Autotransfusion Systems Product Details 9.6.4. Terumo Interventional Systems Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.7. SARSTEDT 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Cardiopulmonary Autotransfusion Systems Product Details 9.7.4. Sarstedt Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.8. FRESENIUS GROUP 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Cardiopulmonary Autotransfusion Systems Product Details 9.8.4. Fresenius GROUP Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.9. REDAX S.P.A 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Cardiopulmonary Autotransfusion Systems Product Details 9.9.4. Redax S.p.A Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin 9.10. GLOBAL BLOOD RESOURCES 9.10.1. Business Overview 9.10.2. Company Basic Information 9.10.3. Cardiopulmonary Autotransfusion Systems Product Details 9.10.4. Global Blood Resources Cardiopulmonary Autotransfusion Systems Production, Revenue and Gross Margin CHAPTER 10. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET VALUE CHAIN ANALYSIS 10.1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS INDUSTRIAL CHAIN ANALYSIS 10.2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. CONSUMER ANALYSIS 10.3.1. Consumer 1 10.3.2. Consumer 2 10.3.3. Consumer 3 10.3.4. Consumer 4

• Medtronic Plc.
• Advancis Surgical
• Haemonetics Corporation
• LivaNova PLC
• Stryker Corporation
• Terumo Interventional Systems
• Sarstedt
• Fresenius GROUP
• Redax S.p.A
• Global Blood Resources
• Atrium Medical Corp.
• Redax

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting